NASDAQ:CMMB
Chemomab Therapeutics Ltd. Stock News
$0.735
+0.0098 (+1.35%)
At Close: May 02, 2024
Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update
07:00am, Wednesday, 24'th Apr 2024
TEL AVIV, Israel, April 24, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflamma
Chemomab (CMMB) Up on Fast Track Designation to CM-101 for PSC
01:32pm, Thursday, 16'th Nov 2023
The FDA bestows Fast Track designation to Chemomab's (CMMB) pipeline candidate, CM-101, for the treatment of primary sclerosing cholangitis. Stock rises.
Chemomab Therapeutics Ltd. (CMMB) Q1 2023 Earnings Call Transcript
11:20am, Sunday, 14'th May 2023
Chemomab Therapeutics Ltd. (NASDAQ:CMMB ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Barbara Lindheim - Consulting Vice President Investor & Public Relations Dale Pf
Chemomab to Present at the Oppenheimer 33rd Annual Healthcare Conference
07:00am, Monday, 06'th Mar 2023
TEL AVIV, Israel , March 6, 2023 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative the
Chemomab (CMMB) Stock Gains 30% on FDA Clearance
11:43am, Tuesday, 21'st Feb 2023
There's potentially positive news for the medical community as well as investors of Chemomab (NASDAQ: CMMB ) today. CMMB stock is moving higher because Chemomab has good news on the regulatory front,
Chemomab Therapeutics stock soars after FDA clears IND for SSc treatment
08:25am, Tuesday, 21'st Feb 2023
Shares of Chemomab Therapeutics Ltd. CMMB, -0.51% shot up 46.9% in premarket trading Tuesday, after the Israel-based biotechnology company said the U.S. Food and Drug Administration cleared its Invest
Chemomab Therapeutics Ltd. (CMMB) Q3 2022 Earnings Call Transcript
12:00pm, Friday, 11'th Nov 2022
Chemomab Therapeutics Ltd. (NASDAQ:CMMB ) Q3 2022 Earnings Conference Call November 11, 2022 8:00 AM ET Company Participants Barbara Lindheim - Consulting Vice President Investor & Public Relations Da
Chemomab Therapeutics to Present at Upcoming Scientific Conferences
07:00am, Friday, 28'th Oct 2022
TEL AVIV, Israel , Oct. 28, 2022 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative th
Chemomab Therapeutics Ltd. (CMMB) CEO Dale Pfost on Q2 2022 Results - Earnings Call Transcript
02:40pm, Friday, 12'th Aug 2022
Chemomab Therapeutics Ltd. (NASDAQ:CMMB ) Q2 2022 Earnings Conference Call August 12, 2022 8:00 AM ET CompanyParticipants Barbara Lindheim - Consulting Vice President Investor & Public Relations Dale
Chemomab Therapeutics to Report Second Quarter 2022 Financial Results and Provide a Business Update
07:00am, Monday, 01'st Aug 2022
TEL AVIV, Israel , Aug. 1, 2022 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company focused on the discovery and development of innovative the
Chemomab Therapeutics to Participate in H.C. Wainwright Global Investment Conference
07:00am, Wednesday, 18'th May 2022
TEL AVIV, Israel , May 18, 2022 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative th
Chemomab Therapeutics Ltd. (CMMB) CEO Dale Pfost on Q1 2022 Results - Earnings Call Transcript
05:43pm, Thursday, 12'th May 2022
Chemomab Therapeutics Ltd. (NASDAQ:CMMB ) Q1 2022 Earnings Conference Call May 11, 2022 8:00 AM ET Company Participants Barbara Lindheim - Consulting Vice President Investor & Public Relations Dale Pf
New Strong Sell Stocks for March 14th
08:17am, Monday, 14'th Mar 2022
AVYA, BGS, and CMMB have been added to the Zacks Rank #5 (Strong Sell) List on March 14, 2022.
Chemomab Therapeutics Ltd (CMMB) CEO Dale Pfost on Q4 2021 Results - Earnings Call Transcript
10:48am, Wednesday, 09'th Mar 2022
Chemomab Therapeutics Ltd (CMMB) CEO Dale Pfost on Q4 2021 Results - Earnings Call Transcript
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
07:00am, Thursday, 02'nd Sep 2021
TEL AVIV, Israel, Sept. 2, 2021 /PRNewswire/ -- Chemomab Therapeutics Ltd.
